SELECT trial: Semaglutide reduces the risk of MACE by 20% in adults with overweight or obesity
Results from the SELECT cardiovascular outcomes trial has revealed that semaglutide 2.4mg demonstrated a statistically significant and...
top of page
Browse by category
Search
Aardvark Therapeutics gains Rare Pediatric Disease Designation for Prader-Willi Syndrome
The FDA has granted Aardvark Therapeutics a Rare Pediatric Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare...
MBX Biosciences gains FDA clearance to study MBX 1416 for post-bariatric hypoglycaemia
MBX Biosciences, a clinical stage biopharmaceutical company developing Precision Endocrine Peptide (PEP) therapeutics to treat an array...
AGA supports reintroduction of bipartisan Treat and Reduce Obesity Act
The American Gastroenterological Association (AGA) has announced support for the reintroduced Treat and Reduce Obesity Act (TROA), which...
Benefits of Tele-CBT for post-bariatric surgery patients
Telephone cognitive behavioural therapy (Tele-CBT) intervention is helpful in reducing symptoms of depression, anxiety, binge eating and...
Researchers identify age-specific and sex-specific obesity genes
Researchers from the University of Cambridge have identified several genes that appear to affect obesity risk in certain sexes and ages....
New survey reveals how surgeons define innovation in real life
A recent survey carried out by Sermo, a physician-only online community of more than 1.3 million healthcare providers globally,...
Journal Watch 02/08/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
IFSO-EC, EASO and ECPO issue joint statement on surgical tourism
The International Federation for the Surgery of Obesity and Metabolic Disorders, European Chapter (IFSO-EC), the European Association for...
First subject receives DR10624 for the treatment of obesity and hypertriglyceridemia
Zhejiang Doer Biologics, a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and...
Browse by tag
bottom of page